April 7-8, 2005
Hyatt Regency
Bethesda
Bethesda, Maryland
Presented by:
The National Cancer Institute (NCI)
Food and Drug Administration (FDA)
Centers for Medicare and Medicaid Services (CMS)
National Electrical Manufacturers Association (NEMA)
The focus of the Sixth National Forum on Biomedical Imaging in Oncology was on Quantitative Oncologic Imaging. The meeting opened with updates from NEMA, the U.S. Food and Drug Administration (FDA), and Center for Medicare and Medicaid Services (CMS), summarizing progress made on issues raised at the 2004 Forum. Also in the opening session, the NCI updated on the review of the clinical trials process and current imaging activities.
The afternoon session on the first day included a keynote presentation on the critical need for quantitative oncologic imaging, then proceeded with presentations on tumor response criteria, imaging in clinical trials of cancer therapeutic agents, biological issues in quantitative oncologic imaging, high sensitivity and specificity agents, and detection devices.
Panel discussions were held following the morning and afternoon sessions.
Meeting Program and Presentations:
April 7
| 8:30 am | Welcome and Opening Remarks | Daniel Sullivan, MD | |
8:45 am | Welcome from the National Electrical Manufacturers Association (NEMA) | Thomas McCausland | |
9:00 am | Welcome from NCI/DCTD and Update on NCI Review of Clinical Trials Process | James Doroshow, Ph.D. | |
9:15 am | Update on NCI Imaging Activities | Daniel Sullivan, MD | |
9:40 am | Update from FDA/Center for Devices and Radiological Health | Daniel Schultz, MD | |
10:30 am | Update from FDA/Center for Drug Evaluation and Research | Janet Woodcock, MD | |
10:50 am | Update from Center for Medicare and Medicaid Services (CMS) | Stephen Phurrough, MD, MPA | |
11:10 am | Panel Discussion | Sullivan, McCausland, Doroshow, Schultz, Woodcock, Phurrough, George Mills | |
1:00 pm | Keynote Address: The Need for Quantitative Imaging in Oncology | Richard Schilsky, MD | |
1:45 pm | Tumor Response Criteria: Anatomic (RECIST) & Functional Approaches | Larry Schwartz, MD | |
2:15 pm | Imaging Trials of Cancer Therapeutic Agents: Pharmaceutical Perspective | Susan Galbraith, MD, PhD | |
3:15 pm | Biological Issues in Oncology Imaging | Roy Herbst, MD, PhD | |
3:45 pm | Development of High Sensitivity & Specificity Imaging Agents: Challenges & Opportunities | Michael Tweedle, PhD | |
4:15 pm | Detection Device/Acquisition Issues | Kyle Myers, PhD | |
4:45 pm | Panel Discussion | Schilsky, Schwartz, Galbraith, Herbst, Tweedle, Myers, Paula Jacobs, PhD |
April 8
| 8:00 am | The Forefront in Imaging Processing: Anatomic/Physiologic Approaches | Richard Robb, PhD | |
8:35 am | The Forefront in Imaging Processing: PET/Molecular Approaches | Joel Karp, PhD | |
9:10 am | Building Large Publicly-Available Image Archives | Larry Clarke, PhD | |
10:00 am | Standardizing Image Acquisition | Jeff Evelhoch, PhD | |
10:30 am | The Data Explosion: How Can We Achieve Inter-operability?
| Moderator: Larry Clarke, PhD
James Williams, PhD
F David Rollo, MD, PhD
Wesley Turner, PhD
| |
11:30 am | Panel Discussion | Robb, Karp, Clarke, Evelhoch, Williams, Rollo, Turner |
|
